The impact of trisomy 21 on early human hematopoiesis.
Anindita
A
Roy
Gillian
G
Cowan
Paresh
P
Vyas
Irene
I
Roberts
D001853:Bone Marrow / Q000254:growth & development / Q000378:metabolism / Q000473:pathology; D060833:Cellular Microenvironment; D004314:Down Syndrome / Q000097:blood* / Q000150:complications / Q000235:genetics* / Q000473:pathology; D005333:Fetus; D050982:GATA1 Transcription Factor / Q000235:genetics; D006410:Hematopoiesis / Q000235:genetics*; D006801:Humans; D007947:Leukemia, Megakaryoblastic, Acute / Q000150:complications / Q000235:genetics* / Q000473:pathology; D007955:Leukemoid Reaction / Q000150:complications / Q000235:genetics* / Q000473:pathology; D009154:Mutation; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000235:genetics* / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000235:genetics* / Q000473:pathology
D050982:GATA1 Transcription Factor; C494688:GATA1 protein, human
Down syndrome; acute megakaryoblastic leukemia; fetal liver; hematopoiesis; neonatal leukemia; transient abnormal myelopoiesis; trisomy 21